'Bioethicists' Proliferate Despite Undefined Career Track

Bioethics is "definitely a growth industry," says Norman Fost. So you want to be a bioethicist. Join the rather crowded, ever-growing club. Bioethics centers and programs continue to proliferate as doctors, lawyers, and persons of every conceivable background remain intrigued by issues ranging from human cloning to managed health care. As Arthur Caplan, the director of the Center for Bioethics at the University of Pennsylvania, puts it, bioethics has moved from "infancy into adolescence." Th

Written byEugene Russo
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share


Bioethics is "definitely a growth industry," says Norman Fost.
So you want to be a bioethicist. Join the rather crowded, ever-growing club. Bioethics centers and programs continue to proliferate as doctors, lawyers, and persons of every conceivable background remain intrigued by issues ranging from human cloning to managed health care. As Arthur Caplan, the director of the Center for Bioethics at the University of Pennsylvania, puts it, bioethics has moved from "infancy into adolescence."

There's something of a transition under way: Traditionally viewed as a multidisciplinary area, bioethics, which first started to pick up steam in the early '70s, has started to come into its own as a legitimate interdisciplinary field. Most persons currently working in bioethics got their formal training not in bioethics programs, but in fields like law, medicine, philosophy, religion, or sociology. That appears to be changing as degree programs gain popularity.

"It certainly seems like there's ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies